Similarly, the number of cells showing subcellular co-localization of COL5A1 and HK2 was increased in patients with GBM (G4) and G3 glioma compared to that in G1 and G2 glioma (Figures 6d and S8). This evidence concerns the gene HK2 and central nervous system cancer.